Xu et al. observed significant reduction in the number and frequency of the activated Tregs (CD4 + CD25 + FOXP3 + Helios + T cells) in peripheral blood of the MG patients during active stage, concluding that decreased activated Tregs could be a critical contributor to the pathogenesis of MG50. The gene discussed is CD4; the disease is myasthenia gravis.